Chang, Nancy T.

Affiliated Entities

Apex Bioventures Acquisition Corp	Charles River Laboratories Holdings Inc	Galera Therapeutics, Inc.	Helix Acquisition Corp	Immix Biopharma, Inc.
Sciclone Pharmaceuticals, Inc.	TANOX, INC.	Wandt Offshore, Inc.

Add a document

Description
Summary
Document Type	Academic Paper Corporate Document - Internal Corporate Document - Public Court Document Equity Research Government Document - Federal Government Document - State Government Document - Local FBI File Public Records Request Response - FOIA Public Records Request Response - State Non-Profit Report Police Report White Paper
Document Date
Document Source
Source URL
File
	If you would like to be credited for contributing this document, make sure to sign in or sign up first. Once uploaded, your document may not be immediately visible to the public as we review each document for legal issues. Thanks for your patience!

Outside Counsel (264)

	Last Name	First Name	Middle Name	Firm	Location
	Rojanakiathavorn	Matthew		Kilpatrick Townsend & Stockton, LLP
	Ropp	Traci		Genentech, Inc.	Palo Alto, CA
	ROTHSCHILD	CYNTHIA		Kilpatrick Townsend & Stockton, LLP	Winston-salem, Nc,
	RUCKER	SUSAN		OFFICE OF TECHNOLOGY TRANSFER	ROCKVILLE, MD
	Russell	Dean	Wall	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Saab	Karam	J.	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Sahasrabudhe	Kiran		Wilson Sonsini Goodrich & Rosati, PC
	Sai	Donna		Kilpatrick Townsend & Stockton, LLP	San Francisco, CA
	Sanders	Carl	E.	Kilpatrick Townsend & Stockton, LLP	Winston-salem, Nc,
	Sanders	Jason	A.	Kilpatrick Townsend & Stockton, LLP
	SANI	BABAK		Kilpatrick Townsend & Stockton, LLP
	Sani	Barmak		Kilpatrick Townsend & Stockton, LLP
	Sarles	Matthew	T.	Kilpatrick Townsend & Stockton, LLP
	Schaffer	Christopher	P.	Kilpatrick Townsend & Stockton, LLP
	Schiff	J.	Michael	Kilpatrick Townsend & Stockton, LLP	San Francisco, CA
	Schwartz	Timothy	R.	Genentech, Inc.	South San Francisco, CA
	Seka	Johann	Georg	Kilpatrick Townsend & Stockton, LLP	San Francisco, CA
	SERUNIAN	LESLIE		Morgan & Finnegan, LLP
	Shaffer	William	L.	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Sherman	Daniel		Jones Day Reavis & Pogue	South San Francisco, CA
	Shin	Elinor		Jones Day Reavis & Pogue
	SHMILOVICH.	MICHAEL			Washington, DC
	Shurtz	Kenneth	R.	Kilpatrick Townsend & Stockton, LLP
	Slone	David	N.	Townsend & Townsend & Crew LLP	San Francisco, CA
	Smith	James		DAVID E. BROOK
	Snyder	Joseph	R.	Kilpatrick Townsend & Stockton, LLP	SAN FRANCISCO, CA
	Spaeth	Susan	M.	Kilpatrick Townsend & Stockton, LLP	Palo Alto, CA
	Sripathy	Kanchan		Kilpatrick Townsend & Stockton, LLP
	Stahnke	Jessica	C.	Kilpatrick Townsend & Stockton, LLP
	Stockwell	Mitchell	G.	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Svoboda	Craig		Jones Day Reavis & Pogue	CINCINNATI, OH
	Swehla	Aaron		Kilpatrick Townsend & Stockton, LLP
	Sydenham	Ryan		Sharp Kabushiki Kaisha
	TABIBI	ARDESHIR		Townsend & Townsend & Crew LLP
	Tan	Lee	K.	Genentech, Inc.	South San Francisco, CA
	Thomas	Tiffany	B.	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Tong	Bei		Sheridan Ross, PC
	Trimble	Alexander	R.	Mintz, Levin, Cohn, Ferris, Glovsky & Popeo,...
	Tsang	Thomas		Jones Day Reavis & Pogue
	Tse	Michael		Kilpatrick Townsend & Stockton, LLP	SAN FRANCISCO, CA
	Turton	Michael	J.	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Vapnek	Paul	W.	Kilpatrick Townsend & Stockton, LLP
	Vepa	Suryanarayana		Sheridan Ross, PC
	Verga	Michael		Kilpatrick Townsend & Stockton, LLP	Washington, DC
	Wade	Kathryn		Paul Hastings LLP
	Wainwright	Renae		Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Walker	Marlan		Kilpatrick Townsend & Stockton, LLP
	Walsh	Christopher		Arnold & Porter, LLP
	Wang	Min		Jones Day Reavis & Pogue	Cambridge, MA
	Weber	Kenneth	A	Baker Donelson Bearman Caldwell & Berkowitz,...	Nashville, TN
	Weight	Clark		Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Wetherald	Cort		Kilpatrick Townsend & Stockton, LLP	San Diego, CA
	Williams	Camilla	Camp	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Williams	Tiffany		Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Willink	Christopher		Kilpatrick Townsend & Stockton, LLP
	Wooten	Alyson	L	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Wray	Caroline	K.	Kilpatrick Townsend & Stockton, LLP	Winston-salem, Nc,
	Wylie	Roger	D.	306866, Leydig, Voit & Mayer, Ltd	CHICAGO, IL
	Yeung	Bonny	G.	Genentech, Inc.	South San Francisco, CA
	YIN	LU		Kilpatrick Townsend & Stockton, LLP
	Young	Daniel	Taylor	Kilpatrick Townsend & Stockton, LLP	New York, NY
	Zhang	Wei		Jones Day Reavis & Pogue	New York, NY
	Zigmant.	John		Kilpatrick Townsend & Stockton, LLP	SAN FRANCISCO, CA
	Zylstra	Eric	J.	Kilpatrick Townsend & Stockton, LLP

264 Rows Total	Page 3 of 3 | Go To

Filter By Form All Records 3 4 4/A 5 SC 13G SC 13G/A From To

	Date	Entity	Form Number	Description
	4/10/2026		SCHEDULE 13D
	4/9/2026	Galera Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	12/11/2025	Immix Biopharma, Inc.	4	Statement of changes in beneficial ownership of securities
	9/17/2025	Immix Biopharma, Inc.	3	Initial statement of beneficial ownership of securities
	6/5/2025	Wandt Offshore, Inc.	4	Statement of changes in beneficial ownership of securities
	2/26/2025	Galera Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	1/2/2025	Galera Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	1/2/2025	Galera Therapeutics, Inc.	3	Initial statement of beneficial ownership of securities
	6/18/2024	Wandt Offshore, Inc.	4	Statement of changes in beneficial ownership of securities
	5/2/2023	Wandt Offshore, Inc.	3	Initial statement of beneficial ownership of securities
	10/19/2020	Helix Acquisition Corp	3	Initial statement of beneficial ownership of securities
	2/1/2019		SC 13G
	10/16/2017	Sciclone Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	6/9/2017	Sciclone Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	9/29/2016	Sciclone Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	8/30/2016	Sciclone Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	6/13/2016	Sciclone Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	6/12/2015	Sciclone Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	2/13/2015	Sciclone Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	2/5/2015		SC 13G/A
	8/19/2014	Sciclone Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	6/16/2014	Sciclone Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	2/13/2014		SC 13G
	9/19/2013	Sciclone Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	9/19/2013	Sciclone Pharmaceuticals, Inc.	3	Initial statement of beneficial ownership of securities
	5/11/2010	Charles River Laboratories Holdings Inc	4	Statement of changes in beneficial ownership of securities
	5/10/2010		3	Initial statement of beneficial ownership of securities
	5/12/2009	Charles River Laboratories Holdings Inc	4	Statement of changes in beneficial ownership of securities
	11/19/2008	Charles River Laboratories Holdings Inc	4	Statement of changes in beneficial ownership of securities
	5/13/2008		4	Statement of changes in beneficial ownership of securities
	5/13/2008		4/A
	2/26/2008		4	Statement of changes in beneficial ownership of securities
	11/2/2007		4	Statement of changes in beneficial ownership of securities
	11/2/2007		3	Initial statement of beneficial ownership of securities
	6/7/2007		3	Initial statement of beneficial ownership of securities
	2/14/2007		SC 13G/A
	11/6/2006		4	Statement of changes in beneficial ownership of securities
	9/20/2006		4	Statement of changes in beneficial ownership of securities
	9/6/2006		4	Statement of changes in beneficial ownership of securities
	8/30/2006		4	Statement of changes in beneficial ownership of securities
	8/24/2006		4	Statement of changes in beneficial ownership of securities
	8/16/2006		4	Statement of changes in beneficial ownership of securities
	8/9/2006		4	Statement of changes in beneficial ownership of securities
	8/2/2006		4	Statement of changes in beneficial ownership of securities
	7/26/2006		4	Statement of changes in beneficial ownership of securities
	7/12/2006		4	Statement of changes in beneficial ownership of securities
	7/5/2006		4	Statement of changes in beneficial ownership of securities
	6/23/2006		4	Statement of changes in beneficial ownership of securities
	6/21/2006		4	Statement of changes in beneficial ownership of securities
	6/14/2006		4	Statement of changes in beneficial ownership of securities

67 Rows Total	Page 1 of 2 | Go To

	Date Recorded	Party	Role	Document Type	Document No.	Invention Title
	6/13/2003	Tanox, Inc.	Assignee	Application Publication	09974338 20020061308	Bcl-2 gene proteins conjugated to a ligand for a cell surface antigen of... Bcl-2 gene proteins conjugated to a ligand for a cell surface antigen of...
	6/13/2003	Tanox, Inc.	Assignee	Application Publication	10061910 20030059834	Methods to generate and identify monoclonal antibodies to a large number... Methods to generate and identify monoclonal antibodies to a large number...
	1/6/1992	Tanox Biosystems, Inc.	Assignee	Application Patent	07785565 5866129	Method Of Producing An Antibody With A Peptide Corresponding To Membra N... Method Of Producing An Antibody With A Peptide Corresponding To Membra N...
	1/5/1987	Centocor, Inc.	Assignee	Application Patent	06834212 4808536	Immunochemical Method For Detection Of Antibody Against Htlv-iii Core Pr... Immunochemical Method For Detection Of Antibody Against Htlv-iii Core Pr...
	9/22/1986	Centocor, Inc.	Assignee	Application Patent	06707066 4774175	Immunochemical Methods For The Detection Of Antibody Against Htlv-iii Immunochemical Methods For The Detection Of Antibody Against Htlv-iii
	3/28/1985	Centocor, Inc.	Assignee	Application Patent	06693866 9328391	Cloning And Expression Of Hiv-1 Dna Cloning And Expression Of Hiv-1 Dna
	1/3/1984	Centocor, Inc.	Assignee	Application Patent	06547941 4596774	Method Of Preparing Murine Monoclonal Antibodies Against Cell-free Produ... Method Of Preparing Murine Monoclonal Antibodies Against Cell-free Produ...

7 Rows Total

Chang, Nancy T. has not been involved in any trademark assignment transactions in the PlainSite database.

Incoming Payments

This individual has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This individual has not disclosed any outgoing payments to lobbying groups.

Affiliated Entities

• Apex Bioventures Acquisition Corp
• Charles River Laboratories Holdings Inc
• Galera Therapeutics, Inc.
• Helix Acquisition Corp
• Immix Biopharma, Inc.
• Sciclone Pharmaceuticals, Inc.
• TANOX, INC.
• Wandt Offshore, Inc.